Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Staccato Alprazolam vs Oral Alprazolam in Healthy Participants
NCT05626439Phase 1Completed
- Sponsor
- UCB
- Start
- Dec 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of alprazolam in seizure and epilepsy (2 arms), sponsored by UCB. Primary endpoints: Area under the plasma concentration-time curve from time 0 to infinity, Area under the plasma concentration-time curve from time 0 to the last quantifiable concentration and 1 more. Started Dec 2022; status: completed.
02
Drugs
alprazolam
03
Conditions
seizureepilepsy
Beyond the preview
Go deeper on NCT05626439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05626439.